Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli

Molecular Pharmacology

Volumn 76, Issue 5, 2009, Pages 1031-1043

  Bui, Peter H ^a,b   Hankinson, Oliver ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; 7,8 DIHYDRO 7,8 DIHYDROXYBENZO[A]PYRENE; 7,8 DIHYDRODIOL 9,10 EPOXIDE; 9,10 DIHYDROBENZO[A]PYRENE; AFLATOXIN B1; BENZO[A]PYRENE; CARCINOGEN; CUMENE HYDROPEROXIDE; CYTOCHROME P450; CYTOCHROME P450 2S1; CYTOCHROME P450 REDUCTASE; EPOXIDE; HYDROPEROXIDE DERIVATIVE; NAPHTHALENE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STYRENE; SYNTHETIC DNA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SUBSTRATE; ESCHERICHIA COLI; GENE EXPRESSION; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; METABOLITE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; CARCINOGENS, ENVIRONMENTAL; CYTOCHROME P-450 ENZYME SYSTEM; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, SYNTHETIC; HUMANS; MOLECULAR SEQUENCE DATA; NADP; TRANSFECTION;

EID: 70350434097     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.057752     Document Type: Article

References (59)

1. Anari MR, Khan S, Jatoe SD, and O'Brien PJ (1997) Cytochrome P450 dependent xenobiotic activation by physiological hydroperoxides in intact hepatocytes. Eur J Drug Metab Pharmacokinet 22:305-310. (Pubitemid 28075157)
2. Baldwin RM, Shultz MA, and Buckpitt AR (2005) Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4. J Pharmacol Exp Ther 312:857-865.
3. Barnes HJ, Arlotto MP, and Waterman MR (1991) Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. Proc Natl Acad Sci U S A 88:5597-5601. (Pubitemid 21914792)
4. Barr DP, Martin MV, Guengerich FP, and Mason RP (1996) Reaction of cytochrome P450 with cumene hydroperoxide: ESR spin-trapping evidence for the homolytic scission of the peroxide O-O bond by ferric cytochrome P450 1A2. Chem Res Toxicol 9:318-325.
5. Barr DP and Mason RP (1995) Mechanism of radical production from the reaction of cytochrome c with organic hydroperoxides. An ESR spin trapping investigation. J Biol Chem 270:12709-12716.
6. Bernhardt R, Makower A, Jänig GR, and Ruckpaul K (1984) Selective chemical modification of a functionally linked lysine in cytochrome P-450 LM2. Biochim Biophys Acta 785:186-190. (Pubitemid 15147159)
7. Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, and de Waziers I (2007) Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731-742. (Pubitemid 47263068)
8. Brash AR and Song WC (1995) Structure-function features of flaxseed allene oxide synthase. J Lipid Mediat Cell Signal 12:275-282.
9. Brian WR, Sari MA, Iwasaki M, Shimada T, Kaminsky LS, and Guengerich FP (1990) Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae. Biochemistry 29:11280-11292.
10. Bui PH, Hsu EL, and Hankinson O (2009) Fatty acid hydroperoxides support CYP2S1-mediated bioactivation of benzo[a]pyrene7,8-dihydrodiol. Mol Pharmacol 76:1044-1052.
11. Catalano CE and Ortiz de Montellano PR (1987) Oxene transfer, electron abstraction, and cooxidation in the epoxidation of stilbene and 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by hemoglobin. Biochemistry 26:8373-8380.
12. Chou MW, Yang SK, Sydor W, and Yang CS (1981) Metabolism of 7,12-dimethylbenz(a)anthracene and 7-hydroxymethyl-12-methylbenz(a)anthracene by rat liver and microsomes. Cancer Res 41:1559-1564. (Pubitemid 11146796)
13. Crespi CL and Miller VP (1997) The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase. Pharmacogenetics 7:203-210. (Pubitemid 27290634)
14. Downie D, McFadyen MC, Rooney PH, Cruickshank ME, Parkin DE, Miller ID, Telfer C, Melvin WT, and Murray GI (2005) Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res 11:7369-7375. (Pubitemid 41507696)
15. Gallagher EP, Kunze KL, Stapleton PL, and Eaton DL (1996) The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol 141:595-606.
16. Gao J, Lauer FT, Dunaway S, and Burchiel SW (2005) Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracene (DMBA) induced spleen cell immunotoxicity. Toxicol Sci 86:68-74. (Pubitemid 41511351)
17. Gelboin HV (1980) Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60:1107-1166.
18. Griffin BW, Marth C, Yasukochi Y, and Masters BS (1980) Radical mechanism of aminopyrine oxidation by cumene hydroperoxide catalyzed by purified liver microsomal cytochrome P-450. Arch Biochem Biophys 205:543-553. (Pubitemid 11134750)
19. Guengerich FP, Gillam EM, and Shimada T (1996) New applications of bacterial systems to problems in toxicology. Crit Rev Toxicol 26:551-583.
20. Guengerich FP, Wu ZL, and Bartleson CJ (2005) Function of human cytochrome P450s: characterization of the orphans. Biochem Biophys Res Commun 338:465-469.
21. Hankinson O (1995) The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307-340.
22. Joseph P and Jaiswal AK (1994) NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci U S A 91:8413-8417. (Pubitemid 24273674)
23. Karlgren M, Miura S, and Ingelman-Sundberg M (2005) Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol 207 (2 Suppl):57-61.
24. Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, and Sutter TR (1998) Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19:1847-1853. (Pubitemid 28474651)
25. Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, Curran S, and Murray GI (2005) Cytochrome P450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res 11:3758-3765. (Pubitemid 40685593)
26. Lewis DF and Pratt JM (1998) The P450 catalytic cycle and oxygenation mechanism. Drug Metab Rev 30:739-786.
27. Lindhe O, Granberg L, and Brandt I (2002) Target cells for cytochrome P450-catalysed irreversible binding of 7,12-dimethylbenz[a]anthracene (DMBA) in rodent adrenal glands. Arch Toxicol 76:460-466. (Pubitemid 34985264)
28. Mitsuda M and Iwasaki M (2006) Improvement in the expression of CYP2B6 by co-expression with molecular chaperones GroES/EL in Escherichia coli. Protein Expr Purif 46:401-405.
29. Nadin L and Murray M (1999) Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes. Biochem Pharmacol 58:1201-1208. (Pubitemid 29381521)
30. Nebert DW and Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162.
31. Nikfarjam L, Izumi S, Yamazaki T, and Kominami S (2006) The interaction of cytochrome P450 17alpha with NADPH-cytochrome P450 reductase, investigated using chemical modification and MALDI-TOF mass spectrometry. Biochim Biophys Acta 1764:1126-1131. (Pubitemid 43912540)
32. Nordblom GD, White RE, and Coon MJ (1976) Studies on hydroperoxide- dependent substrate hydroxylation by purified liver microsomal cytochrome P-450. Arch Biochem Biophys 175:524-533.
33. Omura T and Sato R (1964a) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
34. Omura T and Sato R (1964b) The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem 239:2379-2385.
35. Ortiz de Montellano P (1995) Oxygen Activation and Reactivity, in Cytochrome P450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano PR ed) pp 245-303, Plenum Press, New York.
36. Otey CR, Bandara G, Lalonde J, Takahashi K, and Arnold FH (2006) Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. Biotechnol Bioeng 93:494-499. (Pubitemid 43232175)
37. Potenza N, Salvatore V, Raimondo D, Falanga D, Nobile V, Peterson DL, and Russo A (2007) Optimized expression from a synthetic gene of an untagged RNase H domain of human hepatitis B virus polymerase which is enzymatically active. Protein Expr Purif 55:93-99. (Pubitemid 47259688)
38. Rivera SP, Saarikoski ST, and Hankinson O (2002) Identification of a novel dioxininducible cytochrome P450. Mol Pharmacol 61:255-259. (Pubitemid 34112798)
39. Rivera SP, Wang F, Saarikoski ST, Taylor RT, Chapman B, Zhang R, and Hankinson O (2007) A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia. J Biol Chem 282:10881-10893. (Pubitemid 47100738)
40. Rylander T, Neve EP, Ingelman-Sundberg M, and Oscarson M (2001) Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem Biophys Res Commun 281:529-535. (Pubitemid 32928187)
41. Saarikoski ST, Rivera SP, Hankinson O and Husgafvel-Pursiainen K (2005a) CYP2S1: a short review. Toxicol Appl Pharmacol 207 (2 Suppl):62-69.
42. Saarikoski ST, Wikman HA, Smith G, Wolff CH, and Husgafvel-Pursiainen K (2005b) Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry. J Histochem Cytochem 53:549-556. (Pubitemid 40593968)
43. Schulze J, Tschöp K, Lehnerer M, and Hlavica P (2000) Residue 285 in cytochrome P450 2B4 lacking the NH(2)-terminal hydrophobic sequence has a role in the functional association of NADPH-cytochrome P450 reductase. Biochem Biophys Res Commun 270:777-781. (Pubitemid 30444782)
44. Shen S and Strobel HW (1993) Role of lysine and arginine residues of cytochrome P450 in the interaction between cytochrome P4502B1 and NADPH-cytochrome P450 reductase. Arch Biochem Biophys 304:257-265. (Pubitemid 23214179)
45. Shimada T, Gillam EM, Oda Y, Tsumura F, Sutter TR, Guengerich FP, and Inoue K (1999) Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo-[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chem Res Toxicol 12:623-629. (Pubitemid 29354745)
46. Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM, Ferguson J, and Ibbotson SH (2003) Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336-1343. (Pubitemid 36514866)
47. Stark K and Guengerich FP (2007) Characterization of orphan human cytochromes P450. Drug Metab Rev 39:627-637. (Pubitemid 47355742)
48. Thakker DR, Yagi H, Lehr RE, Levin W, Buening M, Lu AY, Chang RL, Wood AW, Conney AH, and Jerina DM (1978) Metabolism of trans-9,10-dihydroxy-9,10- dihydrobenzo[a]pyrene occurs primarily by arylhydroxylation rather than formation of a diol epoxide. Mol Pharmacol 14:502-513. (Pubitemid 8354262)
49. Thum T, Erpenbeck VJ, Moeller J, Hohlfeld JM, Krug N, and Borlak J (2006) Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ Health Perspect 114:1655-1661. (Pubitemid 44718269)
50. Voznesensky AI and Schenkman JB (1994) Quantitative analyses of electrostatic interactions between NADPH-cytochrome P450 reductase and cytochrome P450 enzymes. J Biol Chem 269:15724-15731. (Pubitemid 24982378)
51. Wang MY and Liehr JG (1994) Identification of fatty acid hydroperoxide cofactors in the cytochrome P450-mediated oxidation of estrogens to quinone metabolites. Role and balance of lipid peroxides during estrogen-induced carcinogenesis. J Biol Chem 269:284-291. (Pubitemid 24026657)
52. Wang SL, He XY, and Hong JY (2005) Human cytochrome P450 2S1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine. Drug Metab Dispos 33:336-340.
53. Wardenga R, Hollmann F, Thum O, and Bornscheuer U (2008) Functional expression of porcine aminoacylase 1 in E. coli using a codon optimized synthetic gene and molecular chaperones. Appl Microbiol Biotechnol 81:721-729.
54. Wester MR, Stout CD, and Johnson EF (2002) Purification and crystallization of N-terminally truncated forms of microsomal cytochrome P450 2C5. Methods Enzymol 357:73-79.
55. Wislocki PG, Juliana MM, MacDonald JS, Chou MW, Yang SK, and Lu AY (1981) Tumorigenicity of 7,12-dimethylbenz[a]anthracene, its hydroxymethylated derivatives and selected dihydrodiols in the newborn mouse. Carcinogenesis 2:511-514.
56. Wood AW, Goode RL, Chang RL, Levin W, Conney AH, Yagi H, Dansette PM, and Jerina DM (1975) Mutagenic and cytotoxic activity of benzol[a]pyrene 4,5-, 7,8-,and 9,10-oxides and the six corresponding phenols. Proc Natl Acad Sci U S A 72:3176-3180.
57. Wu ZL, Sohl CD, Shimada T, and Guengerich FP (2006) Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 69:2007-2014. (Pubitemid 43894320)
58. Yasukochi Y and Masters BS (1976) Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem 251:5337-5344.
59. Yeh HC, Tsai AL, and Wang LH (2007) Reaction mechanisms of 15-hydroperoxyeicosatetraenoic acid catalyzed by human prostacyclin and thromboxane synthases. Arch Biochem Biophys 461:159-168.